Company Overview and News

SeaDrill's Shares Ride High on Confirmed Restructuring Plans

11h zacks
SeaDrill Limited’s (SDRL - Free Report) shares have increased 64.68% to eventually close at 36.56 cents on Apr 18, reflecting investors’ optimism on the stock after the company’s restructuring plan won approval from the U.S. Bankruptcy Court. Looking Back Hit by the industry downturn, SeaDrill had been going through a rough patch over the last two years, with its shares plummeting more than 91% during the time frame, owing to increased debts and bankruptcy fears.
Upvote Downvote

What Analysts Expect from Halliburton’s 1Q18 Earnings

2018-04-18 marketrealist
In 1Q18, analysts expect Halliburton (HAL) to post adjusted earnings per share (or EPS) of $0.41. This means Wall Street analysts expect HAL’s adjusted earnings to fall 23% in 1Q18 from the 4Q17 adjusted earnings of $0.53 per share. Despite the management’s expectation of higher prices for its offerings and the positive effects of lower costs from various cost reduction initiatives, a weaker international upstream market could result in a 1Q18 earnings decline.
Upvote Downvote

Seadrill Gets US Court Approval For Bankruptcy Exit Plan

2018-04-17 rigzone
WILMINGTON, Del., April 17 (Reuters) - A U.S. judge said on Tuesday he would approve Seadrill Ltd's plan to exit its Chapter 11 bankruptcy, in which the global offshore oil and gas drilling company would shed billions of dollars of debt and raise $1 billion in new investment.
Upvote Downvote

Martin J. Whitman, Third Avenue Management Founder, Dies at 93 - Bloomberg

2018-04-17 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Baker Hughes, a GE Company: Will 1Q18 Earnings Decline?

2018-04-16 marketrealist
In 1Q18, analysts expect $0.06 in adjusted earnings per share (or EPS) for Baker Hughes, a GE Company (BHGE). So Street analysts expect BHGE’s adjusted earnings to decline sharply, by 58% from the 4Q17 adjusted earnings of $0.15 per share. Low upstream energy activity and challenging pricing in the subsea business, a muted Turbomachinery segment due to lower LNG (liquefied natural gas) activity, a lower-margin downstream backlog, and decreased transaction services in the oilfield equipment segment are all expected to result in the 1Q18 earnings decline.
Upvote Downvote

[Press] Middle East Oilfield Services Market - Analysis of Growth, Trends and Forecasts (2018 - 2023)

2018-04-12 oilvoice
The Middle East produces more than 30% of the crude oil produced globally, and had 385 drilling rigs in October 2017. After the crude oil price started increasing in the second half of 2016, the oil & gas activity in the region started stabilizing slowly. In November 2017, crude oil price crossed USD 60 barrel mark. The region is expected to witness an increase in oil & gas activity in 2018, with Saudi Arabia being the leader, and Iran and Iraq to register a high growth rate.
Upvote Downvote

Parker Drilling Is It Cheap Enough?

2018-04-10 seekingalpha
PKD has reached a multi-year low yesterday at 0.483, and it is hard to figure out what caused this brutal fall after analyzing the recent fourth-quarter 2017 results.
Upvote Downvote

Why Nabors’s Free Cash Flow Turned Negative in 2017

Nabors Industries’ (NBR) cash from operating activities (or CFO) crashed 88% in 2017 versus 2016. NBR generated $62.8 million CFO in 2017. Despite 15% higher revenues in 2017 versus 2016, adverse changes in working capital led to the fall in CFO in 2017.
Upvote Downvote

The 5 Oilfield Companies with the Lowest Free Cash Flow

We discussed 2017’s top five free cash flow (or FCF) earners in the oilfield equipment and services (or OFS) industry in our previous series. In this series, we’ll analyze the lowest five FCF generators in 2017 in the OFS industry, excluding the offshore drillers. We’ve selected companies in the OFS industry with market capitalizations over $100 million. Free cash flow is cash flow from operations less capital expenditure.
Upvote Downvote

Why Is Nabors Industries (NBR) Up 4.2% Since Its Last Earnings Report?

2018-03-29 zacks
A month has gone by since the last earnings report for Nabors Industries Ltd. (NBR - Free Report) . Shares have added about 4.2% in that time frame.
Upvote Downvote

Why FMSA’s Free Cash Flow Improved in 2017

Fairmount Santrol Holdings’ (FMSA) CFO (cash from operating activities) increased significantly in 2017 compared to 2016. FMSA generated $144.8 million in CFO in 2017. In 2016, FMSA’s CFO was much lower than it was in the previous year, mostly due to a fall in its revenue in 2016 over 2015.
Upvote Downvote

[Press] ADES International Holding Ltd Results for the Year Ended 31 December 2017

2018-03-19 oilvoice
(London & Dubai, 19 March 2018) ADES International Holding ("ADES" or "the Company"), the London-listed company providing offshore and onshore oil and gas drilling and production services in the Middle East and Africa through its subsidiaries, announces today its full-year results for the year ended 31 December 2017.
Upvote Downvote

5 Stocks Trading Under $10 That Have Massive Upside Potential

2018-03-10 247wallst
While Most of Wall Street focuses on large and mega-cap stocks, as they provide a degree of safety and liquidity, many investors are limited in the number of shares they can buy, as many of the biggest companies, especially the technology giants, trade in the low to mid-hundreds per share — all the way up to over $1,000. At those steep prices, it’s pretty hard to get any decent share count leverage.
Upvote Downvote

Was Chevron Smart or Just Lucky in the Permian Basin? - Bloomberg

2018-03-07 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: G6359F103